March 28 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* Nuvo Pharmaceuticals enters into pennsaid 2 pct license agreement with Sayre Therapeutics Pvt Ltd. For India, Sri Lanka, Bangladesh and Nepal
* Nuvo Pharmaceuticals Inc - has received an upfront payment and is eligible to receive milestone payments and a double-digit royalty on net sales
* Says Nuvo will supply pennsaid 2 pct to sayre on an exclusive basis from its manufacturing facility in varennes, québec
* Nuvo Pharmaceuticals Inc - agreement to distribute, market and sell pennsaid 2 pct in India, Sri Lanka, Bangladesh and Nepal ( territory)
* Nuvo Pharmaceuticals Inc - expect to complete pennsaid 2 pct out-licensing agreements for other territories throughout 2017 and 2018 Source text for Eikon: ID:nPn9W7M34a Further company coverage: NRI.TO